The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for reproxalap for the treatment of the signs and symptoms of dry eye disease. Reproxalap is a ...
People only know they have ocular hypertension at an eye exam. It doesn’t cause symptoms. Find out how to lower high eye ...
Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...
Imagine a day when blurry vision becomes a barrier to your daily activities, and a world where glasses seem like the only ...